Please login to the form below
implant
This page shows the latest implant news and features for those working in and with pharma, biotech and healthcare.
FDA approves Allergan’s biodegradable glaucoma implant drug
Durysta (bimatoprost implant) is the first biodegradable, sustained-release implant for IOP in patients with open-angle glaucoma or ocular hypertension. ... As the first FDA-approved intracameral, biodegradable sustained-release implant providing
Latest news
-
Bayer bulks up in women’s health again with non-hormonal contraceptive deal
The German drugmaker is already a major player in the women’s health market, selling a range of contraceptive products including oral and injectable hormonal products and implants, and is one ... Bayer hasn’t had the happiest recent history in the
-
Servier faces manslaughter trial over weight loss drug deaths
from defective breast implants manufactured by Poly Implant Prothese (PIP).
-
HIV meeting hears progress towards vaccine and cure
Meanwhile, Merck &Co/MSD presented preliminary results with a new HIV drug – islatravir (MK-8591) – that it believes could offer a year of anti-HIV activity from a single implant, rather
-
Elon Musk’s NeuraLink applies to trial ‘brain-machine interface’
to surgically implant the threads that is “as simple and automated as LASIK” – the laser surgery commonly used for vision correction – and eventually might not even need anaesthesia. ... The basic concepts on offer at NeuraLink aren’t
-
CHMP nod for Alexion, GSK drugs, revocation for Lartruvo
Other drugs gaining recommendation included:. Molteni Farmaceutici’s Sixmo (buprenorphine) an opioid dependence implant treatment that releases low levels of buprenorphine into the patient’s body for six months.
Bayer bulks up in women’s health again with non-hormonal contraceptive deal
Servier faces manslaughter trial over weight loss drug deaths
HIV meeting hears progress towards vaccine and cure
Elon Musk’s NeuraLink applies to trial ‘brain-machine interface’
CHMP nod for Alexion, GSK drugs, revocation for Lartruvo
More from news
Approximately 1 fully matching, plus 94 partially matching documents found.
Latest Intelligence
-
The transatlantic opioid crisis
such as the group litigation order (GLO) for silicone breast implants.
-
Delivering the promise of regenerative medicine
Once only imaginable in science fiction, the latest applications include engineered skin tissue to treat burns victims, custom-grown bones for implants and joint replacements, personalised dietary treatments using gut bacteria
-
Changes to look out for in Medical Devices Regulations
PIP. In 2000, it was discovered that Poly Implant Prothèse (PIP) had been using industrial-grade silicone instead of the medical-grade specified for the CE mark in the manufacture of ... The CE mark for PIP implants was consequently withdrawn, and
-
Tightening medical device safety
Building on the lessons learned from recent events (such as the French PIP breast implant scandal), the EU regulations require that each device bears a unique device identifier (UDI) and that ... In this regard, medical device users of implantable
-
Deal Watch - May 2017
its bupivacaine collagen implant for treatment of post-operative pain. ... Innocoll (US/IE). Gurnet Point (US). Company acquisition. Company with US pre-registration bupivacaine collagen implant for post-operative pain.
The transatlantic opioid crisis
Delivering the promise of regenerative medicine
Changes to look out for in Medical Devices Regulations
Deal Watch - May 2017
More from intelligence
Approximately 0 fully matching, plus 15 partially matching documents found.
Latest appointments
-
Promimic appoints CEO
Larsson joins the nano-materials developer from Dentsply Sirona Implants, where he was most recently director for global market development. ... Magnus brings valuable global leadership experience and a wide network from his time in the dental implant
-
Histogenics names former MedImmune president as CEO
This includes lead candidate NeoCart – a cartilage tissue implant in phase III trials.
Promimic appoints CEO
Histogenics names former MedImmune president as CEO
More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.
Latest from PMHub
-
Building the hospital of the future
latest technologies around artificial intelligence, deep learning, data analytics, genomics, home‑based healthcare, robotics, and 3D printing of tissues and implants.”.
-
Courageous Conversation ep.9: Elon Musk's Neuralink and the Future of the Computer Brain Interface
Natalie Yeadon, Co-Owner and Managing Director at Impetus Digital, provides insight on Elon Musk's Neuralink and the Future of the Computer Brain Interface. Address:. Impetus Digital. WaterPark Place. 20 Bay Street, 11th Floor. Toronto. Ontario. M5J
More from PMHub
Approximately 1 fully matching, plus 1 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Medical Writers (All levels) Editorial / Scientific Leads & ...
-
Highly Competitive Remuneration packages
-
CEO Pricing & Market Access, UK
-
Six figure salary
- Embattled Biogen talks up Aduhelm
- First oral antiviral drug for COVID-19 reviewed by Health Canada
- David Hunt launches independent agency The Considered
- One dose of AZ’s COVID-19 vaccine ‘highly effective’ against severe disease from variants
- bluebird bio gears up for split
- EU identifies first five ‘promising’ COVID-19 drugs as part of therapeutics strategy
- Digitalizing Muskuloskeletal Care to Improve Patient Outcomes and Reduce Cost
- Accelerating Drug Development Timelines with Big Data Analytics
- A Lucid Group Thirsty Thursday Special: Beautiful Rejects
- EU “still interested” in Valneva COVID vaccine despite UK snub
- US orders 1.4 million more doses of Regeneron antibody cocktail
- Taking centre stage: the role of behaviour change initiatives in the management of long-term conditions
No results were found
PMHub
Envision Pharma Group
We are a global leader in the medical affairs space. Our purpose-built software and scientific solutions make us a unique...
Latest intelligence
- Health literacy in the time of COVID-19
- In a time when much of the media’s focus is on the ongoing COVID-19 pandemic and the differences in vaccination rates between various regions, countries, and socioeconomic groups, improving health...
- Rare thoughts & outcomes - navigating pathways to better outcomes in rare
- ...
- How to pick the perfect training program for your healthcare professionals
- You know your team needs training. But not all training providers and programs are created equal. Last week, we shared the benefits of working with specialist learning and development (L&D)...
